SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ARIAD Pharmaceuticals
ARIA 23.990.0%Feb 17 4:00 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: DewDiligence_on_SI who wrote (2909)11/1/2013 4:06:53 PM
From: glass 0.5 full  Read Replies (1) of 4474
 
Right, they write about it in the text, but I find it ... let's say, "odd" ... that they would put together an entire tabulation of adverse events, and then specifically fail to include only the single AE that blew up the trial.

What does that even mean? Who writes a paper that way?

It's the same thing they did with the ASH presentation slides -- whole tables of "Treatment Emergent AEs" but nothing about thromboembolism until you get to a footnote, which offers no data on incidence rate.

I feel like I'm reading a research report by a tobacco company.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News